https://www.statnews.com/2020/04/29/patients-drug-companies-grapple-cancer-trials-coronavirus/?utm_source=STAT+Newsletters&utm_campaign=a124ea3d93-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-a124ea3d93-149692869

STAT Plus: Patients, drug makers grapple with how to continue cancer trials during the coronavirus

By ANDREW JOSEPH

KHULOUD T. AL-JAMAL, DAVID MCCARTHY & IZZAT SUFFIAN/WELLCOME

The coronavirus pandemic has thrown a wrench into plans for hundreds of clinical trials. But some investigators and sponsors are pushing ahead.

READ MORE